May 27 (Reuters) - MedMira Inc MIR.V :
* MEDMIRA PROVIDES AN UPDATE ON THE NEW IN VITRO DIAGNOSTIC
MEDICAL DEVICES REGULATION (IVDR) IN THE EUROPEAN MARKET
* MEDMIRA INC - RECEIVED CE MARK FOR THREE PRODUCTS IN 2022
AND
HAS FOUR ADDITIONAL APPLICATIONS CURRENTLY PENDING WITH
REGULATORY BODY
* MEDMIRA INC - INFORMED THAT ALL APPLICATIONS HAVE BEEN
ACCEPTED
AND WILL BE FORWARDED TO COMPETENT AUTHORITY FOR FINAL CE
MARKING
Source text for Eikon: ID:nGNXcgnz9p
Further company coverage: MIR.V
((Reuters.Briefs@thomsonreuters.com;))